Skip to main content

Day: February 16, 2025

Smith+Nephew steps forward with innovative Sports Medicine foot & ankle repair solutions in Australia and New Zealand

Written by Customer Service on . Posted in Public Companies.

First in market to offer Adjustable Tensioning Technology* for insertional Achilles reconstruction and lateral ankle instability repair *After anchor insertion Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of a comprehensive foot & ankle repair portfolio in Australia and New Zealand (ANZ) with proprietary adjustable tensioning technology. The ULTRABRIDGE◊ Adjustable Achilles Reconstruction and ULTRABRACE◊ Adjustable Ankle Instability Techniques are changing the way foot & ankle surgeons perform these repairs by allowing them to refine and optimise suture tension after anchor insertion. The ability to adjust tension for specific patients allows the surgeon to give the precise amount of range-of-motion to that patient depending on the patient’s level of activity. The surgeon...

Continue reading

FTI Consulting Establishes Healthcare & Human Services Industry Practice in Australia

Written by Customer Service on . Posted in Public Companies.

SYDNEY, Feb. 16, 2025 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the establishment of a dedicated Healthcare & Human Services industry practice in Australia with the appointment of Nathan Schlesinger as a Senior Managing Director and practice leader and Nicki Doyle as a Senior Managing Director, as well as six Managing Directors. Mr. Schlesinger is based in Sydney and has 25 years of experience advising public- and private-sector health and aged care clients in Australia, the United States and Southeast Asia. Ms. Doyle has 16 years of experience supporting public- and private-sector aged care clients in Australia and internationally to navigate aged care policy, reform, regulation and changes to the aged care market. “FTI Consulting is uniquely positioned as the only independent and fully dedicated...

Continue reading

UPDATE – GCL and RF Acquisition Corp. Complete Business Combination, GCL to Commence Trading on Nasdaq Under Ticker “GCL” and Announces Bell Ringing to Commemorate Listing

Written by Customer Service on . Posted in Mergers And Acquisitions.

GCL and RF Acquisition Corp. Have Closed the Business Combination on February 13, 2025 GCL’s Ordinary Shares and Warrants Will Begin Trading on Nasdaq on February 14, 2025, Under Ticker Symbols “GCL” and “GCLWW,” Respectively GCL to Ring the Closing Bell at Nasdaq on Friday, February 14, 2025SINGAPORE, Feb. 16, 2025 (GLOBE NEWSWIRE) — GCL Global Limited (“GCL” or the “Company”), a leading provider of games and entertainment content based in Asia, today announced the successful completion of its business combination (the “Business Combination”) with RF Acquisition Corp. (Nasdaq: RFAC) (“RFAC”), a special purpose acquisition company, resulting in each of GCL and RFAC becoming a wholly-owned subsidiary of GCL Global Holdings Ltd. (“GCL Group” or the “Combined Company”). On February 14, 2025, GCL Group’s ordinary shares will commence...

Continue reading

ReShape Lifesciences® Announces Pricing of Upsized $6.0 Million Public Offering

Written by Customer Service on . Posted in Public Companies.

IRVINE, Calif., Feb. 15, 2025 (GLOBE NEWSWIRE) — ReShape Lifesciences® (“ReShape” or the “Company”) (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the pricing of its public offering of 2,575,107 units at a public offering price of $2.33 per unit. Each unit consists of one common share (or pre-funded warrant to purchase one common share in-lieu thereof) and one warrant to purchase one common share. The warrants, which are not exercisable unless and until approved by ReShape stockholders, will be initially exercisable at a price of $5.83 per share, subject to standard adjustments for dividends, splits and similar events, and also subject to adjustment upon a one-time reset on the Reset Date (as described in the warrants), subject to a floor price described therein. The...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.